Overview

DIalysis Symptom COntrol-Pruritus Outcome Trial

Status:
Not yet recruiting

Trial end date:
2023-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test whether or not a medication called nabilone, which is a synthetic (non-natural) medication derived from cannabis, compared to placebo improves symptoms of itch in hemodialysis as measured by visual analog scales.

Phase:

Phase 3

Details

Lead Sponsor:

University of Manitoba

Collaborator:

Population Health Research Institute

Treatments:

Dronabinol
Nabilone